Prosecution Insights
Last updated: October 25, 2026

Fay Kaplun & Marcin, LLP -- Bsc

Technology area: Medical Devices & Mechanical Engineering

11 pending office actions • 1 client • 9 examiners • 6 art units • 0 of 11 (0%) have an AI response strategy ready • 25 patents granted in the last 365 days

Analysis

Fay Kaplun & Marcin, LLP -- BSC has 11 pending office actions in Medical Devices & Mechanical Engineering and 4323 career applications. The profile shows active prosecution alongside a broad application history for the firm.

The resolved allowance rate is 87.9%, and the average is 3.92 office actions per allowance. This historical combination indicates that allowances were common among resolved matters but generally followed multiple office-action exchanges. Counsel can use the figures to plan resources, while the BSC pending matters should be evaluated through their own prosecution records.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=4323 apps, methodology: how we score firms)

87.9%
Allowance Rate
n=4323
+0.56σ
Allowance Rate (norm)
n=4323
3.9
OAs to Allowance
n=2527
+0.23σ
OAs to Allow (norm)
n=2527
1163 days
Time to Allowance
n=2527
+6.4pp
Interview Lift
n=4323
30.4%
RCE Rate
n=4323
8.9%
Appeal Rate
n=4323

Rejection Performance (% of received rejections ultimately overcome)

84.5%
§101 Overcome
n=406
81.9%
§102 Overcome
n=1287
82.1%
§103 Overcome
n=1975
82.3%
§112 Overcome
n=1051

Specialization & Scale

H04W, H04L, A61B
Top CPC Subclasses
43%
Top-3 CPC Share
n=4323
3
Practitioners
n=4323
1441.0
Apps / Practitioner
n=4323

Portfolio Summary

11
Total Pending OAs
7
Non-Final OAs
3
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (27%)
6
Medium (55%)
1
Easy (9%)
1
Unknown (9%)

Rejection Statute Mix

BucketCases
§103 only6 (55%)
§112 only1 (9%)
Multi-statute (no §101)3 (27%)
No statute on record1 (9%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
11
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

110 h
Manual time on pending OAs
22 h
Time saved (low, 20%)
38 h
Time saved (mid, 35%)
1.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LABRANCHE, BROOKE N 3 72.1% +17.0%
YANG, YI-SHAN 1 70.4% +53.0%
GABR, MOHAMED GAMIL 1 80.6% +21.9%
HOLLM, JONATHAN ADAM 1 50.5% +52.7%
RASSAVONG, ERIC 1 70.7% +35.4%
ROBERTS, ANNA L 1 55.7% +39.8%
MANNAN, MIKAIL A 1 68.3% +24.0%
PRICE, NATHAN R 1 53.4% +38.7%
TOWA, RENE T 1 49.5% +17.5%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19065709 HEMOSTASIS CLIP WITH COLLAPSIBLE CAPSULE GABR, MOHAMED GAMIL —

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18933685 INTERNAL OSTOMY BAG RASSAVONG, ERIC —
18626986 DEVICE AND METHOD FOR TREATING TISSUE USING A PATCH MANNAN, MIKAIL A —
18485875 VARIABLE EXPOSURE NEEDLE PRICE, NATHAN R —

Interview Candidates (11)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19079032 ECHOGENIC PATTERN FOR COMPONENT DISTINGUISHABILITY YANG, YI-SHAN 79d
19065709 HEMOSTASIS CLIP WITH COLLAPSIBLE CAPSULE GABR, MOHAMED GAMIL —
19030671 OVER THE SCOPE CLIP WITH REPOSITIONAL CAPABILITY HOLLM, JONATHAN ADAM —
18962980 OVER THE SCOPE BIFURCATION ASSEMBLY WITH CLIP RELEASE MECHANISM LABRANCHE, BROOKE N —
18933685 INTERNAL OSTOMY BAG RASSAVONG, ERIC —
18902199 NON-SHEDDING COUPLING METHOD AND SYSTEM FOR RELOADABLE HEMOSTASIS CLIP LABRANCHE, BROOKE N —
18819326 CRIMP ATTACHMENT OF CLIP FOR RELOADABLE HEMOSTASIS DEVICE LABRANCHE, BROOKE N —
18679019 BIOPSY FORCEPS WITH TISSUE PIERCING MEMBER ROBERTS, ANNA L —

Client Portfolio (1 client)

Client (Assignee)Pending OAs
Boston Scientific 11

Top Art Units

Art UnitApps
37715
37912
37981
37811
37741
37831

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19079032 ECHOGENIC PATTERN FOR COMPONENT DISTINGUISHABILITY BOSTON SCIENTIFIC CORPORATION YANG, YI-SHAN 3798 §103 Non-Final OA 79d Pending Mar 13, 2025
19065709 HEMOSTASIS CLIP WITH COLLAPSIBLE CAPSULE BOSTON SCIENTIFIC CORPORATION GABR, MOHAMED GAMIL 3771 §112 Non-Final OA — Pending Feb 27, 2025
19030671 OVER THE SCOPE CLIP WITH REPOSITIONAL CAPABILITY BOSTON SCIENTIFIC CORPORATION HOLLM, JONATHAN ADAM 3771 §103 Final Rejection — Pending Jan 17, 2025
18962980 OVER THE SCOPE BIFURCATION ASSEMBLY WITH CLIP RELEASE MECHANISM BOSTON SCIENTIFIC CORPORATION LABRANCHE, BROOKE N 3771 §103 Non-Final OA — Pending Nov 27, 2024
18933685 INTERNAL OSTOMY BAG BOSTON SCIENTIFIC CORPORATION RASSAVONG, ERIC 3781 §102§103 Non-Final OA — Pending Oct 31, 2024
18902199 NON-SHEDDING COUPLING METHOD AND SYSTEM FOR RELOADABLE HEMOSTASIS CLIP BOSTON SCIENTIFIC CORPORATION LABRANCHE, BROOKE N 3771 Other Non-Final OA — Pending Sep 30, 2024
18819326 CRIMP ATTACHMENT OF CLIP FOR RELOADABLE HEMOSTASIS DEVICE BOSTON SCIENTIFIC CORPORATION LABRANCHE, BROOKE N 3771 §103 Non-Final OA — Pending Aug 29, 2024
18679019 BIOPSY FORCEPS WITH TISSUE PIERCING MEMBER BOSTON SCIENTIFIC CORPORATION ROBERTS, ANNA L 3791 §103 Non-Final OA — Pending May 30, 2024
18626986 DEVICE AND METHOD FOR TREATING TISSUE USING A PATCH BOSTON SCIENTIFIC CORPORATION MANNAN, MIKAIL A 3774 §102§103 Non-Final OA — Pending Apr 04, 2024
18485875 VARIABLE EXPOSURE NEEDLE BOSTON SCIENTIFIC CORPORATION PRICE, NATHAN R 3783 §102§103§112 Final Rejection — Pending Oct 12, 2023
18065922 Endoscopic Ultrasound Fine Needle Aspiration Device BOSTON SCIENTIFIC CORPORATION TOWA, RENE T 3791 §103 Final Rejection — Pending Dec 14, 2022

Managing Fay Kaplun & Marcin, LLP -- Bsc's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Fay Kaplun & Marcin, LLP -- Bsc's patent allowance rate?

87.9% of resolved applications prosecuted by Fay Kaplun & Marcin, LLP -- Bsc were allowed, across 4,323 applications in USPTO records.

How many office actions does Fay Kaplun & Marcin, LLP -- Bsc average before allowance?

3.92 office actions per allowed application on average.

How many pending office actions does Fay Kaplun & Marcin, LLP -- Bsc have?

11 pending office actions as of October 2026, for 1 client, before 9 examiners in 6 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month